[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GR851617B - - Google Patents

Info

Publication number
GR851617B
GR851617B GR851617A GR850101617A GR851617B GR 851617 B GR851617 B GR 851617B GR 851617 A GR851617 A GR 851617A GR 850101617 A GR850101617 A GR 850101617A GR 851617 B GR851617 B GR 851617B
Authority
GR
Greece
Prior art keywords
polyvinylpyrrolidone
dihydropyridines
preparations
contain
crosslinked
Prior art date
Application number
GR851617A
Other languages
English (en)
Inventor
Wolfgang Schmidt
Helmut Dr Luchtenberg
Eduard Dr Porges
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6239792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR851617(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of GR851617B publication Critical patent/GR851617B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Jellies, Jams, And Syrups (AREA)
GR851617A 1984-07-04 1985-07-02 GR851617B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843424553 DE3424553A1 (de) 1984-07-04 1984-07-04 Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
GR851617B true GR851617B (el) 1985-11-26

Family

ID=6239792

Family Applications (1)

Application Number Title Priority Date Filing Date
GR851617A GR851617B (el) 1984-07-04 1985-07-02

Country Status (15)

Country Link
EP (1) EP0167909B2 (el)
JP (1) JPH0665644B2 (el)
KR (1) KR920006908B1 (el)
AT (1) ATE71297T1 (el)
AU (1) AU570328B2 (el)
CA (1) CA1255597A (el)
DE (2) DE3424553A1 (el)
DK (1) DK304485A (el)
ES (1) ES8607018A1 (el)
FI (1) FI852610L (el)
GR (1) GR851617B (el)
HU (1) HU197844B (el)
IL (1) IL75686A (el)
PT (1) PT80752B (el)
ZA (1) ZA855017B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
US5015479A (en) * 1987-02-02 1991-05-14 Seamus Mulligan Sustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridine
US5001139A (en) * 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
DE4130173A1 (de) * 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
ATE254909T1 (de) * 1995-03-29 2003-12-15 Shionogi & Co Gelatinkapsel mit eingestellter wasseraktivität
CO4771151A1 (es) * 1996-01-19 1999-04-30 Rachitzky Falicman Pablo Alberto Procedimiento para la elaboracion de una preparacion farmace utica que contiene nifedipina y la preparacion farmaceutica obtenida mediante el mismo
WO2002043704A1 (en) 2000-12-01 2002-06-06 Kyowa Hakko Kogyo Co., Ltd. Composition improved in solubility or oral absorbability
DE10117049A1 (de) * 2001-04-05 2002-10-17 Novartis Ag Zusammensetzung
JP5072748B2 (ja) * 2007-07-10 2012-11-14 株式会社 メドレックス アムロジピンの安定な液剤とゼリー剤
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0078430B2 (de) * 1981-10-29 1993-02-10 Bayer Ag Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
DE3142853A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit nifedipin und verfahren zu ihrer herstellung
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
DE3376198D1 (en) * 1983-11-30 1988-05-11 Siegfried Ag Therapeutic coronary composition in the form of soft gelatine capsules
DE3427402A1 (de) * 1984-07-25 1986-01-30 Bayer Ag, 5090 Leverkusen Neues kombinationspraeparat, verfahren zu seiner herstellung und seine verwendung als arzneimittel

Also Published As

Publication number Publication date
JPH0665644B2 (ja) 1994-08-24
KR860000864A (ko) 1986-02-20
KR920006908B1 (ko) 1992-08-22
PT80752B (pt) 1987-10-20
DE3424553A1 (de) 1986-01-09
JPS6118725A (ja) 1986-01-27
DK304485D0 (da) 1985-07-03
EP0167909B1 (de) 1992-01-08
DE3585107D1 (de) 1992-02-20
EP0167909A3 (en) 1987-10-14
AU4429885A (en) 1986-01-09
ES544787A0 (es) 1986-06-16
ATE71297T1 (de) 1992-01-15
DK304485A (da) 1986-01-05
PT80752A (en) 1985-08-01
AU570328B2 (en) 1988-03-10
HUT41259A (en) 1987-04-28
FI852610L (fi) 1986-01-05
ES8607018A1 (es) 1986-06-16
FI852610A0 (fi) 1985-07-02
HU197844B (en) 1989-06-28
EP0167909B2 (de) 1994-10-19
EP0167909A2 (de) 1986-01-15
IL75686A0 (en) 1985-11-29
IL75686A (en) 1988-11-30
ZA855017B (en) 1986-02-26
CA1255597A (en) 1989-06-13

Similar Documents

Publication Publication Date Title
DE58905732D1 (en) Stereoisomere von n-(r)-1-aryl-ethyl)-1-alkyl-2,2-dichlo-cyclopropancarbonsaeureamiden.
AU7504887A (en) Alpha-aryl-alpha-phenylethyl-1h-1,2,4-triazole-1- propanenitriles
AU1704588A (en) Amino-9,10-secosteroids
AU8093487A (en) Improvement in bromphenriamine, pseudoephedrine therapy
GR851617B (el)
EP0329669A4 (en) PREPARATIONS CONTAINING N, N-DIALKYLALKANAMIDES AND THEIR USE.
AU8293287A (en) 5-benzoxazinyl-and 6-benzothiazinyl-2,3,4,5 tetrahydropyridazin-3-ones
DE68903424D1 (en) Antioxidant.
AU7374387A (en) 2-hydrazono-4,6-dinitrobenthiazolones
JPS6470458A (en) Alkylaminoalkoxyphenyl derivative, manufacture and composition
EG18865A (en) Phenoxypenythioureas, phenoxyphenylisothiourreas and phenoxyphenylcarbodiimides and use thereof for controlling pests.
HU896535D0 (en) 14alpha, 17alpha-etano-estratriene-derivatives
JPS6468346A (en) Substituted anilinophenylthiourea, anilinophenylisothiourea and anilinophenylcarbodiimide
AU587646B2 (en) 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
AU2681888A (en) 8,9-annelated-beta-carbolines and 8,9-annelated-3,4-dihydro- beta-carbolines
TR23713A (tr) Suebstituye edilmis tiouereler,izotiouereler ve korbadiimetiller
ZA886915B (en) 4-azasaccharines,4-aza-dihydro-or-tetrahydro-saccharines and processes for the preparation thereof
DE3575448D1 (de) Zange und zangenanordnung.
AU7105687A (en) Bis-tert-butylamino-substituted-1,3,5- triazines
AU1516888A (en) Des-19-leucine, 20-glutamine, 21-threonine-calcitronin
AU1517888A (en) Des-19-leucine, 20-glutamine, 21-threonine, 22-tyrosine-calcitonin
AU7388587A (en) 2-phenylacetyl-1,3,5-cyclohexanetriones
TR24149A (tr) Fenoksifeniltiouereler,fenoksifenil-izotiouereler, fenoksifenil-karbodiimidler ve
CS854484A1 (en) Rucni pripravek k brouseni britu, vytvorenych ve sroubovici